Philadelphia University + Thomas Jefferson University

Fortina Laboratory

Description

The Cancer Genomics and Bioinformatics Resource (CGBR) at the Sidney Kimmel Cancer Center is a high-throughput facility with expertise in carrying out large scale RNA expression profiling studies, genome-wide association studies (GWAS), copy number variation (CNV), methylation studies and next-generation sequencing (NGS) studies. Our mission is to translate basic research findings to medical innovations. We aim to develop and implement new molecular assays and to guide investigators to the most appropriate genomic approach to discover genetic causes for the most prevalent diseases including cancer.

The CGBR serves investigators in the SKCC and TJU and offers Sanger sequencing, mRNA expression profiling as well as targeted genome sequencing, whole exome sequencing, coding and non-coding RNA-Seq, ChIP-Seq, RIP-seq, BIS-Seq, circulating tumor cell isolation and single cell genome amplification. An experienced team of researchers has the capability to analyze the large amounts of data generated from our state-of-the-art high-throughput microarray and NGS technologies.

 

pmf104

Paolo Fortina, MD, PhD
Professor

Contact Dr. Fortina

Bluemle Life Sciences Building
233 South 10th Street
Suite 1009
Philadelphia, PA 19107

(215) 955-0683